Midas Income & Growth Trust PLC
21 March 2006
21 March 2006
Midas Income & Growth Trust PLC ('the Company')
The Board is pleased to announce that, as envisaged in the recent Prospectus
dated 27 January 2006, the Company has renegotiated the terms of its Bilateral
Term Loan Agreement (the 'Amended Loan Agreement') with Allied Irish Banks PLC
(the 'Bank'). Under the terms of the Amended Loan Agreement, up to £5.5 million
is now available for draw down. The Company's existing fixed rate £2,500,000
drawing under the original fixed loan agreement with the Bank has been repaid
and broken at a one off break cost of £26,836.00 and £2,500,000 has been
re-drawn under the terms of the Amended Loan Agreement on a floating interest
rate basis for an initial three month period at an all-in rate of 5.34565%.
Up to £3,000,000 remains available for drawing under the Amended Loan Agreement
in the future.
Enquiries:
David Thomas, Midas Capital Partners Limited 0151 906 2461
Charles Mearns, Aberdeen Asset Management PLC 0131 313 6442
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.